The recent challenges in global chains have highlighted the necessity of securing vital medications like Ivermectin. Trusting on overseas producers exposes countries to potential vulnerabilities, including shipping delays, expense fluctuations, and even geopolitical risks. Transitioning towards domestic procurement of Ivermectin offers a multitude